Can Multiple Sclerosis Cause Elevated D-Dimer?
Yes, multiple sclerosis can cause elevated D-dimer levels, though this is not a typical or primary feature of the disease itself. The elevation occurs primarily in specific clinical contexts rather than as a direct consequence of MS pathophysiology.
Primary Mechanisms of D-Dimer Elevation in MS
Treatment-Related Elevation
The most clinically significant D-dimer elevation in MS occurs as an immediate response to alemtuzumab treatment 1. This monoclonal antibody therapy causes rapid immune cell lysis, triggering coagulation activation that manifests as an acute D-dimer rise following the first infusion. This represents actual coagulation cascade activation with potential thrombotic risk, warranting consideration of prophylactic low molecular weight heparin in patients receiving this therapy 1.
Inflammatory and Systemic Mechanisms
MS patients demonstrate systemic vascular alterations including endothelial dysfunction and lipid profile abnormalities that extend beyond CNS pathology 2. These systemic changes could theoretically contribute to D-dimer elevation, though this is not well-characterized in the literature.
Critical Clinical Context
D-dimer is NOT a diagnostic marker for MS and should not be used to screen for or monitor the disease. The guideline evidence consistently demonstrates that D-dimer elevation is a sensitive but highly nonspecific marker that increases in numerous conditions including 3:
- Malignancy
- Infection and inflammatory conditions
- Increasing age
- Pregnancy
- Recent surgery or trauma
- Atrial fibrillation
- Stroke
- Disseminated intravascular coagulation
Differential Diagnosis Considerations
When encountering an MS patient with elevated D-dimer, prioritize evaluation for:
- Venous thromboembolism - MS patients have reduced mobility during relapses, increasing VTE risk
- Recent alemtuzumab or other immunotherapy - Check treatment timeline
- Concurrent infection or inflammatory process - Common MS mimics and complications
- Other systemic conditions listed above
The presence of elevated D-dimer in an MS patient should prompt investigation for these alternative explanations rather than being attributed to MS itself 4.
Key Clinical Pitfall
Do not assume D-dimer elevation in MS patients represents thrombotic disease without appropriate clinical probability assessment. The positive predictive value of D-dimer is poor in isolation 5. Use structured clinical decision rules (Wells score) combined with D-dimer results to guide imaging decisions for suspected VTE 6, 3.
In MS patients with suspected cerebral venous thrombosis presenting with atypical neurological symptoms, a normal D-dimer by sensitive immunoassay or ELISA may help identify low-probability cases, though a normal D-dimer does not exclude CVT if clinical suspicion remains high 4.